- Westminster Pharmaceuticals has recalled some of its medications
- Customers using the pills should check with their doctor or pharmacist
The medication in question contains a combination of levothyroxine, called LT4, along with liothyronine, called LT3. Both are synthetic thyroid hormones used when a person’s thyroid gland can be no longer functioning properly.
No adverse effects through these medications had been reported as of August 9, Westminster Pharmaceuticals said; instead, the lots were being recalled out of an abundance of caution.
Because thyroid medications can treat serious disease, the FDA recommends that will consumers continue to take the pills until they can contact their physician or pharmacist for further guidance.
The recall affects 37 unexpired lots of levothyroxine along with liothyronine (Thyroid Tablets, USP) 15, 30, 60, 0 along with 0 milligrams. The company can be reaching out to all wholesale customers to ask them to stop filling prescriptions with the affected pills, which are sold in 100-count bottles.
Consumers with questions about the recall can contact Westminster’s Regulatory Affairs Department on weekdays at 888-354-9939 or email firstname.lastname@example.org.